M Krámer

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

M Krámer, Jos Hermans, E.R. Wijburg et al. · Blood · 1998 · 490 citations

Medicine, Oncology, Pathology +15

Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record

Jason Walonoski, M Krámer, Joseph C. Nichols et al. · Journal of the American Medical Informatics Association · 2017 · 425 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

M Krámer, J. Hermans, Jefferson Parker et al. · Journal of Clinical Oncology · 1996 · 205 citations

Medicine, Oncology, Pathology +17

Mantle-cell lymphoma: a population-based clinical study.

Gerjo A. Velders, Hanneke C. Kluin‐Nelemans, Carla J. de Boer et al. · Journal of Clinical Oncology · 1996 · 189 citations

Medicine, Hematology, Oncology +15

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff et al. · Journal of Clinical Oncology · 2003 · 168 citations

Medicine, Geriatric Medicine, Oncology +13